Balyasny Asset Management’s Ionis Pharmaceuticals IONS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $30.4M | Buy |
+768,648
| New | +$30.4M | 0.05% | 391 |
|
|
2025
Q1 | – | Hold |
0
| – | – | – | 2207 |
|
|
2024
Q3 | – | Sell |
-1,077,321
| Closed | -$51.3M | – | 2151 |
|
|
2024
Q2 | $51.3M | Buy |
+1,077,321
| New | +$51.3M | 0.09% | 219 |
|
|
2023
Q3 | – | Sell |
-125,850
| Closed | -$5.16M | – | 1981 |
|
|
2023
Q2 | $5.16M | Sell |
125,850
-77,616
| -38% | -$3.18M | 0.01% | 763 |
|
|
2023
Q1 | $7.27M | Buy |
+203,466
| New | +$7.27M | 0.02% | 695 |
|
|
2022
Q3 | – | Sell |
-155,533
| Closed | -$5.76M | – | 2535 |
|
|
2022
Q2 | $5.76M | Buy |
+155,533
| New | +$5.76M | 0.02% | 709 |
|
|
2022
Q1 | – | Sell |
-193,120
| Closed | -$5.88M | – | 2295 |
|
|
2021
Q4 | $5.88M | Buy |
193,120
+51,105
| +36% | +$1.56M | 0.02% | 673 |
|
|
2021
Q3 | $4.76M | Sell |
142,015
-121,271
| -46% | -$4.07M | 0.02% | 688 |
|
|
2021
Q2 | $10.5M | Buy |
+263,286
| New | +$10.5M | 0.05% | 454 |
|
|
2021
Q1 | – | Sell |
-44,848
| Closed | -$2.54M | – | 1727 |
|
|
2020
Q4 | $2.54M | Buy |
+44,848
| New | +$2.54M | 0.01% | 698 |
|
|
2019
Q4 | – | Sell |
-253,265
| Closed | -$15.2M | – | 1192 |
|
|
2019
Q3 | $15.2M | Buy |
+253,265
| New | +$15.2M | 0.1% | 270 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 1408 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 1591 |
|
|
2018
Q1 | – | Sell |
-12,500
| Closed | -$629K | – | 1867 |
|
|
2017
Q4 | $629K | Buy |
12,500
+7,400
| +145% | +$372K | ﹤0.01% | 1238 |
|
|
2017
Q3 | $259K | Sell |
5,100
-8,700
| -63% | -$442K | ﹤0.01% | 1387 |
|
|
2017
Q2 | $702K | Buy |
+13,800
| New | +$702K | ﹤0.01% | 988 |
|
|
2017
Q1 | – | Hold |
0
| – | – | – | 1460 |
|
|
2016
Q4 | – | Hold |
0
| – | – | – | 1220 |
|
|
2016
Q1 | – | Sell |
-185,954
| Closed | -$11.5M | – | 1177 |
|
|
2015
Q4 | $11.5M | Buy |
+185,954
| New | +$11.5M | 0.08% | 304 |
|